USA: Researchers have found in a new study that intravenous amino acid (AA) administration was associated with a lower risk of cardiac surgery–associated acute kidney injury (CSA-AKI) across varying...
COPENHAGEN, DENMARK, 31 March 2026 - BioPorto A/S ("BioPorto” or "Company”) (CPH: BIOPOR) today announced that the KDIGO 2026 Clinical Practice Guideline Draft for Acute Kidney Injury (AKI) and Acute... KDIGO publishes 2026 Clinical Practice Guideline Draft for Acute Kidney Injury and Acute Kidney…
High uric acid, medically known as hyperuricemia, occurs when the body produces excessive uric acid through purine breakdown processes, which occur in specific foods and beverages. When left uncontrolled, the condition can lead to many ailments, including gout, and kidney…
Adding the heart medicine dobutamine to standard blood pressure support during surgery reduced new or worsening kidney injury in patients with septic shock, a randomized trial found. Within seven days of surgery, kidney injury occurred in 22.8% of patients receiving dobutamine…
2026-10-28. The following slide deck was published by ProKidney Corp. in conjunction with this event.
Newswise — September 11, 2024 — A noninvasive ultrasound technology called Break Wave™ lithotripsy (BWL) offers a safe and effective new option for treatment of urinary stones, reports a clinical trial in the October issue of The Journal of Urology®, an Official Journal of…
Stones in the urinary tract can cause unbearable pain. Stones, which are hardened clumps of minerals, can form in the kidneys, ureters, bladder, or urethra. The best way to deal with these stones is... In addition, staying up late will…
Calcium and vitamin D supplements are associated with high calcium levels in the blood and urine, which could increase the risk of kidney stones, a new study finds. The results will be presented Tuesday at The Endocrine Society’s 94th Annual Meeting…
In an interview with The American Journal of Managed Care®, Lafayette discussed how povetacicept works, what the interim findings mean for kidney outcomes, and how the safety profile compares with placebo. Lafayette explained that povetacicept is novel because of a…
One year after Biohaven's first TRAP degrader, BHV-1400, was highlighted in the Kidney Week opening plenary, Biohaven's second TRAP degrader for kidney disease expands its Yale-licensed platform into a growing nephrology franchise BHV-1420 is an investigational TRAP™ extracellular protein degrader.
Kidney stones, polycystic kidney disease, IgA nephropathy, acute kidney injury and other kidney conditions.
An article joins this feed when it matches these terms. Each one is also a search of its own.